PRUDMOULI NSI Week ended 07 Aug 2026

Weekly Investor Report

Prudential Sugar Corporation Ltd. · Consumer Defensive · Confectioners

Open interactive chart View report data
Latest close 13.44 INR
0.2% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -14.9% below the Trend Line and sits at 7.0% of its 52-week range. The latest completed week returned 0.2%, after a -9.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.

Setup score 20 out of 100
Latest Close 13.44 INR 7 Aug 2026
1W Return 0.2% latest completed week
4W Return -9.5% short-term follow-through
12W Return -9.4% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.2% Latest completed week; four-week move -9.5%. Indicator stack 0/35 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 36.26% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 0 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -14.9% below the Trend Line and sits at 7.0% of its 52-week range. The latest completed week returned 0.2%, after a -9.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0312-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -9.5% over four weeks, -9.4% over 12 weeks, and -66.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.2%
4W-9.5%
12W-9.4%
26W-25.2%
52W-66.5%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.23Latest activity-pressure read.
Pressure change-130.7%Four-week change in activity pressure.
Leadership-35.10Latest relative-leadership reading.
RS change-2.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength45/100Blend of value, momentum, and quality. Underlying universe rank 56; rank 1 is best.
Value48/100Relative valuation strength. Underlying universe rank 53; rank 1 is best.
Quality47/100Profitability and accounting quality. Underlying universe rank 54; rank 1 is best.
Momentum50/100Medium-term price momentum. Underlying universe rank 51; rank 1 is best.
Growth47/100Revenue and earnings growth. Underlying universe rank 54; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
7.0x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
7.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
0.9%
Gross profit retained from each unit of revenue.
Operating margin
-1.7%
Operating profit retained from revenue.
Free-cash-flow margin
6.3%
Free cash flow generated from revenue.
Return on invested capital
-0.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-1.2%
Latest one-year revenue growth.
EPS growth
7.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

0 positive · 0 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-68.4%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+39.3%Week of 10 Apr.
Worst week-19.8%Week of 20 Mar.
Latest week+0.2%Week of 7 Aug.

Shape of recent returns

Strong gains3
Modest gains9
Flat weeks0
Modest losses7
Sharp losses7
Recent vol5.3%13-week weekly-return volatility.
Base vol8.0%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -5.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape18/100

Trend, activity pressure, participation, and risk combine to a 18/100 tape read.

 Indicator analysis26/100

Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.

Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 36.26%

Next-week expectancy is negative with a 36.26% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors46/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 16 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202613.44 INR0.2%15.79 INR32.82 INR-0.23-35.1039.1KOff
31 Jul 202613.41 INR3.8%16.01 INR32.96 INR-0.05-36.3532.6KOff
24 Jul 202612.92 INR-4.3%16.23 INR33.10 INR0.19-38.6433.1KOff
17 Jul 202613.50 INR-9.1%16.53 INR33.25 INR0.48-38.9736.1KOff
10 Jul 202614.85 INR-1.4%16.83 INR33.40 INR0.75-34.3513.7KOff
3 Jul 202615.06 INR-5.9%17.09 INR33.54 INR0.76-34.853.7KOff
26 Jun 202616.00 INR0.2%17.39 INR33.68 INR0.72-31.310Off
19 Jun 202615.97 INR6.8%17.64 INR33.81 INR0.71-32.428.4KOff
12 Jun 202614.95 INR-3.5%17.96 INR33.95 INR0.67-36.756.6KOff
5 Jun 202615.49 INR1.8%18.32 INR34.10 INR0.72-35.176.5KOff
29 May 202615.21 INR-0.9%18.68 INR34.24 INR0.80-37.67110.2KOff
22 May 202615.35 INR3.4%19.10 INR34.39 INR0.81-38.4939.8KOff
15 May 202614.84 INR-13.4%19.50 INR34.54 INR0.91-41.3198.8KOff
8 May 202617.13 INR2.6%19.91 INR34.70 INR0.99-34.9443.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context